Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Integer Holdings $500 million convertible senior notes offering
The 2.125% convertible notes are due 2028
Constellation Brands $500 million senior notes offering
The investment-grade notes are due 2026
Norwegian Cruise Line $600 million senior secured notes offering
The senior secured notes are due 2028
Synchrony Financial $750 million subordinated notes offering
The investment-grade notes are due 2033
TD SYNNEX $502 million secondary offering
The shares are listed on the NYSE
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Israel Discount Bank $800 million senior notes
We advised Israel Discount Bank on its debut Rule 144A / Regulation S senior notes offering
Deciphera Pharmaceuticals $135.1 million common stock offering
The common stock is listed on the Nasdaq Global Select Market
Bombardier $750 million senior notes offering
The investment-grade senior notes are due 2029